Daniel Tillett
Net worth: 38 M $ as of 2026-05-30
Net worth: 38 M $ as of 2026-05-30
Dr. Daniel Tillett is a Chief Executive Officer, MD & Director at Racura Oncology Ltd. He is on the Board of Directors at Entropy Neurodynamics Ltd. and Racura Oncology Ltd. Dr. Tillett was previously employed as a Non-Executive Director by Simble Solutions Ltd., an Executive Director & Chief Scientific Officer by Race Oncology Ltd., and a Chief Executive Officer by Nucleics Ltd. He received his undergraduate degree from School of Biotechnology & Biomolecular Sciences and a doctorate degree from School of Biotechnology & Biomolecular Sciences.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RACURA ONCOLOGY LTD 10.64% | 2026-05-27 | 20,269,351 ( 10.64% ) | 38 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| RACURA ONCOLOGY LTD | Chief Executive Officer | 2023-11-21 |
| Companies | Position | End |
|---|---|---|
| SIMBLE SOLUTIONS LIMITED | Director/Board Member | 2023-07-02 |
| RACURA ONCOLOGY LTD | Chief Tech/Sci/R&D Officer | 2023-03-22 |
Nucleics Ltd. | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Simble Solutions Ltd.
Simble Solutions Ltd. Packaged SoftwareTechnology Services Develops software for enterprises to manage business and resources | Technology Services |
School of Biotechnology & Biomolecular Sciences
School of Biotechnology & Biomolecular Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleics Ltd. |
Select your edition
All financial news and data tailored to specific country editions